References
- Mayanskiy N, Alyabieva N, Ponomarenko O, Lazareva A, Katosova L, Ivanenko A, Kulichenko T, Namazova-Baranova L, Baranov A. Serotypes and antibiotic resistance of non-invasive Streptococcus pneumoniae circulating in pediatric hospitals in Moscow, Russia. Int J Infect Dis. 2014;20:58–62. doi:10.1016/j.ijid.2013.11.005.
- Hanquet G, Perrocheau A, Kissling E, Bruhl DL, Tarragó D, Stuart J, Stefanoff P, Heuberger S, Kriz P, Vergison A, et al. ECDC Country Experts for Pneumococcal Disease. 2010;28:3920–28. doi:10.1016/j.vaccine.2010.03.069.
- Ceyhan M. Recent advances in pneumococcal conjugate vaccines: a 13-valent pneumococcal conjugate vaccine. J Pediatr Inf. 2011;5:68–73. doi:10.5152/ced.2011.25.
- Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O’Brien KL, Moore MR; Serotype Replacement Study Group. Serotype- specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med. 2013;10(9):e1001517. doi:10.1371/journal.pmed.1001517.
- Clinical WP. Laboratory Standards Institute: performance standards for antimicrobial susceptibility testing: twenty-fourth informational supplement, M100-S24. Clin Lab Stand Inst (CLSI). 2014;34.1-42.
- Tanır Basaranoglu S, Karadag Oncel E, Aykac K, Ozsurekci Y, Cengiz AB, Kara A, Ceyhan M. Invasive pneumococcal disease: from a tertiary care hospital in the post-vaccine era. Hum Vaccin Immunother. 2017;13:962–64. doi:10.1080/21645515.2016.1256519.
- Park SY, Van Beneden CA, Pilishvili T, Martin M, Facklam RR, Whitney CG. Active bacterial core surveillance team. Invasive pneumococcal infections among vaccinated children in the United States. J Pediatr. 2010;156:478–483.e2. doi:10.1016/j.jpeds.2009.10.008.
- Ceyhan M, Gurler N, Yaman A, Ozturk C, Oksuz L, Ozkan S, Keser M, Salman N, Alhan E, Esel D, et al. Serotypes of Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Turkey: baseline evaluation of the introduction of the pneumococcal conjugate vaccine nationwide. Clin Vaccine Immunol. 2011;18:1028–30. doi:10.1128/CVI.00526-10.
- Xue L, Yao K, Xie G, Zheng Y, Wang C, Shang Y, Wang H, Wan L, Liu L, Li C, et al. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates that cause invasive disease among Chinese children. Clin Infect Dis. 2010;50:741–44. doi:10.1086/650534.
- Gounder PP, Bruden D, Rudolph K, Zulz T, Hurlburt D, Thompson G, Bruce MG, Hennessy TW. Re-emergence of pneumococcal colonization by vaccine serotype 19F in persons aged ≥5 years after 13-valent pneumococcal conjugate vaccine introduction-Alaska, 2008-2013. Vaccine. 2018;36:691–97. doi:10.1016/j.vaccine.2017.12.035.
- Lin WJ, Lo WT, Chou CY, Chen YY, Tsai SY, Chu ML, Wang CC, Diagn Microbiol Infect Dis, 2006;56:189–96. doi: 10.1016/j.diagmicrobio.03.016.
- Schroeder MR, Stephens DS. Macrolide resistance in streptococcus pneumoniae. Front Cell Infect Microbiol. 2016;6:98. doi:10.3389/fcimb.2016.00098.